B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1859-1867

  Peterson, Karin E ^a   Sharp, Gordon C ^a   Tang, Haiwen ^a   Braley Mullen, Helen ^a,b  

^a University of Missouri   (United States)

^b WJB Dorn VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HASHIMOTO DISEASE; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; FEMALE; IMMUNOCONJUGATES; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED CBA; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; T-LYMPHOCYTES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0033083948     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Weigle, W. O. 1980. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv. Immunol. 30:159.
2. Braley-Mullen, H., M. Johnson, G. C. Sharp, and M. Kyriakos. 1985. Induction of autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell. Immunol. 93:132.
3. McMurray, R., G. C. Sharp, and H. Braley-Mullen. 1994. Intrathyroidal cell phenotype in murine lymphocytic and granulomatous experimental autoimmune thyroiditis. Autoimmunity 18:93.
4. Braley-Mullen, H., G. C. Sharp, J. T. Bickel, and M. Kyriakos. 1991. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. J. Exp. Med. 173:899.
5. Braley-Mullen, H., G. C. Sharp, H. Tang, K. Chen, M. Kyriakos, and J. T. Bickel. 1998. Interleukin-12 promotes activation of effector cells that induce severe destructive granulomatous form of experimental autoimmune thyroiditis. Am. J. Pathol. 152:1347.
6. Romball, C. G., and W. O. Weigle. 1987. Transfer of experimental autoimmune thyroiditis with T cell clones. J. Immunol. 138:1092.
7. Stull, S., M. Kyriakos, G. C. Sharp, and H. Braley-Mullen. 1988. Prevention and reversal of experimental autoimmune thyroiditis in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development. Cell. Immunol. 117:188.
8. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74.
9. Bluestone, J. A. 1995. New perspectives of CD28-B7 mediated T cell costimulation. Immunity 2:555.
10. Finck, B. K., P. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA41g. Science 265:1225.
11. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7.1 and anti-B7.2 monoclonal antibody treatment on the develpment of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
12. Perrin, P. J., D. Scott, T. A. Davis, G. S. Gray, M. J. Doggett, R. Abe, C. H. June, and M. K. Racke. 1996 Opposing effects of CTLA41g and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J. Neuroimmunol. 65:31.
13. Knoerzer, D. B., R. W. Karr, B. D. Schwartz, and L. J. Mengle-Gaw. 1995. Collagen-induced arthritis in the BB rat: prevention of disease by treatment with CTLA4-Ig. J. Clin. Invest. 96:987.
14. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80:707.
15. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interactions prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
16. Racke, M. K., D. E. Scott, L. Quigley, G. S. Gray, R. Abe, C. H. June, and P. J. Perrin. 1995. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195.
17. Webb, L. C., M. J. Walmsley, and M. Feldmann. 1996. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 26:2320.
18. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25:3060.
19. Hathcock, K. S., G. Laszlo, H. Dickler, J. Bradshaw, P. Linsley, and R. Hodes. 1993. Identification of an alternative CTLA4 ligand costimulatory for T cell activation. Science 262:905.
20. Razi-Wolf, Z., G. J. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89: 421.
21. Walunus, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
22. Gaulton, G. N., J. Bangs, S. Maddock, T. Springer, D. D. Eardley, and T. B. Strom. 1985. Characterization of a monoclonal rat anti-mouse interleukin-2 receptor antibody and its use in biochemical characterization of the murine interleukin-2 receptor. Clin. Immunol. Immunopathol. 36:18.
23. Williams, W. V., M. Kyriakos, G. C. Sharp, and H. Braley-Mullen. 1986. The role of cellular proliferation in the induction of experimental autoimmune thyroiditis (EAT) in mice. Cell. Immunol. 103:96.
24. Tang, H., G. C. Sharp, K. E. Peterson, and H. Braley Mullen. 1998. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene disrupted mice. J. Immunol. 160:155.
25. Tang, H., and H. Braley-Mullen. 1997. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Int. Immunol. 9:679.
26. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 61:4.
27. 4 integrin and intercellular adhesion molecule-1 (ICAM-1) in murine experimental autoimmune thyroiditis. Autoimmunity 23:9.
28. Tandon, N., R. A. Metcalfe, D. Barnett, and A. P. Weetman. 1994. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Q. J. Med. 87:231.
29. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86) and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
30. Stephens, L. A., and T. W. H. Kay. 1995. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int. Immunol. 7:1885.
31. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
32. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russel, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
33. Gause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Lu, X. Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, J. F. Urban, and R. Abe. 1997. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:4082.
34. Griggs, N. D., S. S. Agersborg, R. J. Noelle, J. A. Ledbetter, P. S. Linsley, and K. S. Tung. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:801.
35. Daikh, D. I., B. K. Finck, P. S. Linsley, D. Hollenbaugh, and D. Wofsy. 1997. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J. Immunol. 159:3104.
36. Williams, W. V., M. Kyriakos, G. C. Sharp, and H. Braley-Mullen. 1987. The cellular basis for the Ia restriction in murine experimental autoimmune thyroiditis. Cell. Immunol. 110:35.
37. Stull, S. J., M. Kyriakos, G. C. Sharp, J. T. Bickel, and H. Braley-Mullen. 1990. Effects of anti-I-A and anti-I-E monoclonal antibodies on the induction and expression of experimental autoimmune thyroiditis in mice. Autoimmunity 6:23.
38. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
39. Schweitzer, A. N., F. Borriello, R. C. K. Wong, A. K. Abbas, and A. H. Sharpe. 1997. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158:2713.
40. Verwilghen, J., R. Louis, M. De Boer, P. S. Linsley, G. K. Haines, A. E. Koch, and R. M. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J. Immunol. 153:1378.
41. Herald, K. C., V. Vezys, A. Koons, D. Lenschow, C. Thompson, and J. A. Bluestone. 1997. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 158:984.
42. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
43. Perrin, P. J., J. H. Maldonado, T. A. Davis, C. H. June, and M. K. Racke. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333.
44. Lühder, F., P. Höglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
45. Murphy, M. L., C. R. Engwerda, P. M. Gorak, and P. M. Kaye. 1997. B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol. 159:4460.
46. Walunas, T. L., and J. A. Bluestone. 1998. CTLA4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160:3855.
47. Allison, J. L., A. Stephens, T. W. Kay, C. Kurts, W. R. Heath, J. F. A. P. Miller, and M. F. Krummel. 1998. The threshold for autoimmune T cell killing is influenced by B7.1. Eur. J. Immunol. 28:949.
48. Dubey, C., M. Croft, and S. L. Swain. 1996. Naive and effector, CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:3280.